Form 8K Bausch Health Companies Inc. For: 13 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bausch Health Companies Inc (BHC)
Bausch Health Companies Inc stock price live, this page displays NYSE BHC stock exchange data. View the BHC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bausch Health Companies Inc real time stock price chart below.
What Is the Bausch Health Companies Inc Stock Price Today?
The Bausch Health Companies Inc stock price today is 6.79.
What Is the Stock Symbol for Bausch Health Companies Inc?
The stock symbol for Bausch Health Companies Inc is "BHC."
What Stock Exchange Does Bausch Health Companies Inc Trade On?
Bausch Health Companies Inc is listed and trades on the NYSE stock exchange.
Is Bausch Health Companies Inc a Good Stock to Buy?
Determining whether Bausch Health Companies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BHC quote. (ISIN: CA0717341071)
What Is the Bausch Health Companies Inc Stock Price Today?
The Bausch Health Companies Inc stock price today is 6.79.
What Is the Stock Symbol for Bausch Health Companies Inc?
The stock symbol for Bausch Health Companies Inc is "BHC."
What Stock Exchange Does Bausch Health Companies Inc Trade On?
Bausch Health Companies Inc is listed and trades on the NYSE stock exchange.
Is Bausch Health Companies Inc a Good Stock to Buy?
Determining whether Bausch Health Companies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BHC quote. (ISIN: CA0717341071)
6.82
-0.17(-2.36%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.76
6.94
52 wk Range
4.25
8.69
BHC is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.766.94
52 wk Range
4.258.69
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BHC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
7.43
Upside
+8.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 8K Bausch Health Companies Inc. For: 3 January
- Investing.com
- Form 8K Bausch Health Companies Inc. For: 2 January
- Investing.com
- Form 8K Bausch Health Companies Inc. For: 13 January
- Investing.com
- Form 8K Bausch Health Companies Inc. For: 3 January
- Investing.com
- Form 8K Bausch Health Companies Inc. For: 2 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Bausch Health Companies Inc Company Profile
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Bausch Health Companies Inc SWOT Analysis
Financial Resilience | Bausch Health's Q3 2024 results showcase robust growth, with revenues of $2.51 billion marking a 12% year-over-year increase and 9% organic growth |
Debt Dilemma | Explore the complexities of Bausch Health's $21.5 billion debt burden and its impact on strategic initiatives, including potential bankruptcy concerns |
Strategic Crossroads | Delve into Bausch Health's plans for asset separation, particularly the Bausch+Lomb division, and how debt issues may affect these crucial moves |
Market Sentiment | Analysts offer mixed views, with price targets ranging from $8 to $11, reflecting the tension between strong performance and financial challenges |
Bausch Health Companies Inc Earnings Call Summary for Q2/2025
- Revenue up 5% YoY to $2.53B; Adjusted EBITDA rose 5% to $871M in Q2 2025, marking 9th consecutive quarter of growth
- Completed $7.9B debt refinancing; stock undervalued per InvestingPro analysis despite 40% gain in past 6 months
- Solta Medical revenues up 25%; XIFAXAN grew 10% with 67,000 new patient starts
- 2025 revenue forecast: $4.95B-$5.1B (4% increase); Adjusted EBITDA projection: $2.625B-$2.725B (5% increase)
- Strategic focus on hepatology expertise, new product launches, and preparing for potential IRA pricing impacts in 2027
Last Updated: 2025-10-14, 03:46 p/m
Read Full TranscriptCompare BHC to Peers and Sector
Metrics to compare | BHC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBHCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 6.9x | 18.0x | −0.6x | |
PEG Ratio | 0.02 | −0.52 | 0.00 | |
Price/Book | −4.4x | 1.5x | 2.6x | |
Price / LTM Sales | 0.3x | 2.1x | 3.4x | |
Upside (Analyst Target) | 14.6% | 145.4% | 41.5% | |
Fair Value Upside | Unlock | 33.5% | 5.5% | Unlock |
Analyst Ratings
1 Buy
7 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 7.43
(+8.92% Upside)
Earnings
Latest Release
Oct 29, 2025
EPS / Forecast
0.48 / 1.04
Revenue / Forecast
2.68B / 2.61B
People Also Watch
FAQ
What Is the Bausch Health (BHC) Stock Price Today?
The Bausch Health stock price today is 6.82
What Stock Exchange Does Bausch Health Trade On?
Bausch Health is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Bausch Health?
The stock symbol for Bausch Health is "BHC."
What Is the Bausch Health Market Cap?
As of today, Bausch Health market cap is 2.53B.
What Is Bausch Health's Earnings Per Share (TTM)?
The Bausch Health EPS (TTM) is 0.97.
When Is the Next Bausch Health Earnings Date?
Bausch Health will release its next earnings report on Feb 25, 2026.
From a Technical Analysis Perspective, Is BHC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Bausch Health Stock Split?
Bausch Health has split 3 times.
How Many Employees Does Bausch Health Have?
Bausch Health has 20700 employees.
What is the current trading status of Bausch Health (BHC)?
As of Jan 20, 2026, Bausch Health (BHC) is trading at a price of 6.82, with a previous close of 6.98. The stock has fluctuated within a day range of 6.76 to 6.94, while its 52-week range spans from 4.25 to 8.69.
What Is Bausch Health (BHC) Price Target According to Analysts?
The average 12-month price target for Bausch Health is USD7.43, with a high estimate of USD10 and a low estimate of USD5. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +8.92% Upside potential.
What Is the BHC Premarket Price?
BHC's last pre-market stock price is 6.88. The pre-market share volume is 9,330.00, and the stock has decreased by -0.10, or -1.43%.
What Is the BHC After Hours Price?
BHC's last after hours stock price is 6.78, the stock has decreased by -0.20, or -2.87%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.